TXG logo

10x Genomics, Inc. (TXG) Selling, General & Administrative Expenses

Annual SG&A:

$344.34M+$1.01M(+0.30%)
December 31, 2024

Summary

  • As of today, TXG annual SG&A is $344.34 million, with the most recent change of +$1.01 million (+0.30%) on December 31, 2024.
  • During the last 3 years, TXG annual SG&A has risen by +$86.78 million (+33.69%).
  • TXG annual SG&A is now at all-time high.

Performance

TXG SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGincome statement metrics

Quarterly SG&A:

$75.36M+$921.00K(+1.24%)
September 30, 2025

Summary

  • As of today, TXG quarterly SG&A is $75.36 million, with the most recent change of +$921.00 thousand (+1.24%) on September 30, 2025.
  • Over the past year, TXG quarterly SG&A has dropped by -$6.35 million (-7.77%).
  • TXG quarterly SG&A is now -19.69% below its all-time high of $93.83 million, reached on December 31, 2024.

Performance

TXG Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGincome statement metrics

TTM SG&A:

-$5.93B-$76.32M(-1.30%)
September 30, 2025

Summary

  • As of today, TXG TTM SG&A is -$5.93 billion, with the most recent change of -$76.32 million (-1.30%) on September 30, 2025.
  • Over the past year, TXG TTM SG&A has dropped by -$6.27 billion (-1861.41%).
  • TXG TTM SG&A is now -775.28% below its all-time high of $878.10 million.

Performance

TXG TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

TXG Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+0.3%-7.8%-1861.4%
3Y3 Years+33.7%+2.7%-2149.7%
5Y5 Years+163.2%+46.2%-3303.3%

TXG Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+33.7%-19.7%+2.7%-58.1%at low
5Y5-Yearat high+163.2%-19.7%+46.2%-370.9%at low
All-TimeAll-Timeat high+636.8%-19.7%+744.8%-775.3%at low

TXG Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$75.36M(+1.2%)
$333.34M(-1.9%)
Jun 2025
-
$74.43M(-17.0%)
$339.69M(-2.5%)
Mar 2025
-
$89.73M(-4.4%)
$348.30M(+1.1%)
Dec 2024
$344.34M(+0.3%)
$93.83M(+14.8%)
$344.34M(+2.3%)
Sep 2024
-
$81.70M(-1.6%)
$336.64M(-0.2%)
Jun 2024
-
$83.04M(-3.2%)
$337.35M(-2.4%)
Mar 2024
-
$85.77M(-0.4%)
$345.82M(+0.7%)
Dec 2023
$343.33M(+15.1%)
$86.13M(+4.5%)
$343.33M(+2.2%)
Sep 2023
-
$82.42M(-9.9%)
$336.09M(+2.8%)
Jun 2023
-
$91.51M(+9.9%)
$327.08M(+3.9%)
Mar 2023
-
$83.28M(+5.6%)
$314.90M(+5.6%)
Dec 2022
$298.30M(+15.8%)
$78.89M(+7.5%)
$298.30M(+3.1%)
Sep 2022
-
$73.40M(-7.5%)
$289.29M(+4.1%)
Jun 2022
-
$79.34M(+19.0%)
$277.97M(+4.0%)
Mar 2022
-
$66.67M(-4.6%)
$267.33M(+3.8%)
Dec 2021
$257.56M
$69.88M(+12.6%)
$257.56M(+5.7%)
Sep 2021
-
$62.08M(-9.6%)
$243.66M(+4.5%)
Jun 2021
-
$68.70M(+20.7%)
$233.13M(+11.6%)
DateAnnualQuarterlyTTM
Mar 2021
-
$56.90M(+1.7%)
$208.84M(+3.2%)
Dec 2020
$202.33M(+54.6%)
$55.97M(+8.6%)
$202.33M(+9.3%)
Sep 2020
-
$51.55M(+16.1%)
$185.11M(+11.4%)
Jun 2020
-
$44.42M(-11.9%)
$166.17M(+7.7%)
Mar 2020
-
$50.39M(+30.0%)
$154.33M(+18.0%)
Dec 2019
$130.83M(+48.8%)
$38.76M(+18.8%)
$130.83M(+10.0%)
Sep 2019
-
$32.61M(+0.1%)
$118.98M(+12.8%)
Jun 2019
-
$32.57M(+21.1%)
$105.48M(+12.1%)
Mar 2019
-
$26.89M(-0.0%)
$94.11M(+7.0%)
Dec 2018
$87.94M(+88.2%)
$26.91M(+40.8%)
$87.94M(+13.6%)
Sep 2018
-
$19.11M(-9.9%)
$77.38M(+9.7%)
Jun 2018
-
$21.20M(+2.3%)
$70.56M(+20.5%)
Mar 2018
-
$20.72M(+26.7%)
$58.54M(+25.2%)
Dec 2017
$46.74M
-
-
Dec 2017
-
$16.35M(+33.0%)
$46.74M(+53.8%)
Sep 2017
-
$12.29M(+34.0%)
$30.39M(+67.9%)
Jun 2017
-
$9.17M(+2.8%)
$18.09M(+102.8%)
Mar 2017
-
$8.92M
$8.92M

FAQ

  • What is 10x Genomics, Inc. annual SG&A?
  • What is the all-time high annual SG&A for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. annual SG&A year-on-year change?
  • What is 10x Genomics, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. quarterly SG&A year-on-year change?
  • What is 10x Genomics, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. TTM SG&A year-on-year change?

What is 10x Genomics, Inc. annual SG&A?

The current annual SG&A of TXG is $344.34M

What is the all-time high annual SG&A for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high annual SG&A is $344.34M

What is 10x Genomics, Inc. annual SG&A year-on-year change?

Over the past year, TXG annual SG&A has changed by +$1.01M (+0.30%)

What is 10x Genomics, Inc. quarterly SG&A?

The current quarterly SG&A of TXG is $75.36M

What is the all-time high quarterly SG&A for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high quarterly SG&A is $93.83M

What is 10x Genomics, Inc. quarterly SG&A year-on-year change?

Over the past year, TXG quarterly SG&A has changed by -$6.35M (-7.77%)

What is 10x Genomics, Inc. TTM SG&A?

The current TTM SG&A of TXG is -$5.93B

What is the all-time high TTM SG&A for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high TTM SG&A is $878.10M

What is 10x Genomics, Inc. TTM SG&A year-on-year change?

Over the past year, TXG TTM SG&A has changed by -$6.27B (-1861.41%)
On this page